Sanifit Is A Biopharmaceutical Company Founded In 2007 As A Spin Off From The University Of The Balearic Islandsbased In Spainit Expanded To The U Sin 2016 With A Subsidiary In San Diegothe Company Specializes In Developing Therapies For Calcification Disordersparticularly Those Affecting The Cardiovascular And Renal Systems Sanifit S Lead Candidatesnf472Is An Investigational Drug Aimed At Treating Calcification Related Conditionsthe Company Has Conducted Various Clinical Studiesincluding A Phase 2 Proof Of Concept Study For Calciphylaxis And A Phase 2B Study Assessing Snf472 S Efficacy In Reducing Calcification Progression In End Stage Renal Disease Patientsin 2021Sanifit Was Acquired By Vifor Pharmawhich Will Help Accelerate The Global Development And Commercialization Of Snf472
